Liver Cancer (Oct 2021)

A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion

  • Masatoshi Kudo

DOI
https://doi.org/10.1159/000519749
Journal volume & issue
Vol. 10, no. 6
pp. 539 – 544

Abstract

Read online

No abstracts available.

Keywords